Rezultati
eNauka >
Results >
HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal j
| Title: | HERIZON: A phase 1B/2 open-label study of imu-131 HER2/neu peptide vaccine PLUS standard of care chemotherapy with randomization in phase 2 in patients with HER2/neu overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal j | Authors  : | Laeufle, Rita; ...; Andric, Zoran G   ; ...; Nikolic, Ivan V ; ...; Radosavljevic, Davorin Z; ...; (broj, koautora 16) |
Issue Date: | 2021 | Publication: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X Journal of Clinical Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 39 br. 15 str. e16065-e16065 | DOI: | 10.1200/JCO.2021.39.15_suppl.e16065 | WoS-ID: | 000708120302003 | URI: | https://enauka.gov.rs/handle/123456789/802344 | Project: | Imugene Australia | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.